BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9437632)

  • 1. Screening for psychopathology in the clinical practice.
    Eland-Goossensen A; van de Goor I; Garretsen H; Schudel J
    J Subst Abuse Treat; 1997; 14(6):585-91. PubMed ID: 9437632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric comorbidity in methadone maintained patients.
    Mason BJ; Kocsis JH; Melia D; Khuri ET; Sweeney J; Wells A; Borg L; Millman RB; Kreek MJ
    J Addict Dis; 1998; 17(3):75-89. PubMed ID: 9789161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing comorbidity in substance abusers. Computer assessment and clinical validation.
    Ross HE; Swinson R; Larkin EJ; Doumani S
    J Nerv Ment Dis; 1994 Oct; 182(10):556-63. PubMed ID: 7931203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.
    Hasin D; Samet S; Nunes E; Meydan J; Matseoane K; Waxman R
    Am J Psychiatry; 2006 Apr; 163(4):689-96. PubMed ID: 16585445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing substance use in multiproblem patients: reliability and validity of the Addiction Severity Index in a mental hospital population.
    Appleby L; Dyson V; Altman E; Luchins DJ
    J Nerv Ment Dis; 1997 Mar; 185(3):159-65. PubMed ID: 9091597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Composite International Diagnostic Interview and clinical DSM-III-R criteria checklist diagnoses.
    Janca A; Robins LN; Bucholz KK; Early TS; Shayka JJ
    Acta Psychiatr Scand; 1992 Jun; 85(6):440-3. PubMed ID: 1642126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clustering of multiple substance use and psychiatric diagnoses in opiate addicts.
    Strain EC; Brooner RK; Bigelow GE
    Drug Alcohol Depend; 1991 Mar; 27(2):127-34. PubMed ID: 2055161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for addictive disorders: a discriminant analysis on 374 addicted and 513 nonpsychiatric participants.
    Corcos M; Loas G; Speranza M; Perez-Diaz F; Stephan P; Verrier A; Lang F; Nezelof S; Bizouard P; Venisse JL; Jeammet P
    Psychol Rep; 2008 Apr; 102(2):435-49. PubMed ID: 18567214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of Addiction Severity Index (ASI) for Assessment of Psychiatric Comorbidity in Multi-Site Randomized Controlled Trials.
    Susukida R; Mojtabai R; Amin-Esmaeili M
    J Dual Diagn; 2020; 16(3):312-321. PubMed ID: 32254003
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential response to cognitive therapy in parolees with primary and secondary substance use disorders.
    Nishith P; Mueser KT; Srsic CS; Beck AT
    J Nerv Ment Dis; 1997 Dec; 185(12):763-6. PubMed ID: 9442189
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers.
    Hasin DS; Trautman KD; Miele GM; Samet S; Smith M; Endicott J
    Am J Psychiatry; 1996 Sep; 153(9):1195-201. PubMed ID: 8780425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders.
    Cassano GB; Pini S; Saettoni M; Rucci P; Dell'Osso L
    J Clin Psychiatry; 1998 Feb; 59(2):60-8. PubMed ID: 9501887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of substance use disorders among psychiatric inpatients.
    Lehman AF; Myers CP; Dixon LB; Johnson JL
    J Nerv Ment Dis; 1996 Apr; 184(4):228-33. PubMed ID: 8604032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Co-morbidity: psychiatric disorder of opiate addicts at entry into heroin-assisted treatment].
    Frei A; Rehm J;
    Psychiatr Prax; 2002 Jul; 29(5):251-7. PubMed ID: 12101491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent validity of cocaine and sedative dependence diagnoses in opioid-dependent outpatients.
    Kidorf M; Brooner RK; King VL; Chutuape MA; Stitzer ML
    Drug Alcohol Depend; 1996 Oct; 42(2):117-23. PubMed ID: 8889410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.
    Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET
    J Clin Psychiatry; 2002 Feb; 63(2):126-34. PubMed ID: 11874213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopathology and clinical features in an Italian sample of patients with myofascial and temporomandibular joint pain: preliminary data.
    Nifosì F; Violato E; Pavan C; Sifari L; Novello G; Guarda Nardini L; Manfredini D; Semenzin M; Pavan L; Marini M
    Int J Psychiatry Med; 2007; 37(3):283-300. PubMed ID: 18314857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of screening instruments for mental disorders in general hospital patients.
    Clarke DM; Smith GC; Herrman HE
    Int J Psychiatry Med; 1993; 23(4):323-37. PubMed ID: 8175245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical diagnosis of substance use disorders in private psychiatric populations.
    Miller NS; Belkin BM; Gibbons R
    J Subst Abuse Treat; 1994; 11(4):387-92. PubMed ID: 7966510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.